The EFSD/Sanofi European Diabetes Research Programme in Macrovascular Complications is intended to stimulate and accelerate European research on macrovascular complications. Grants are offered for basic or clinical mechanistic studies. For the former, innovative studies including use of advanced stem cell approaches will be particularly welcome whereas studies involving classical animal models of macrovascular disease will not be considered for funding.
Research will be supported through the award of grants, each of up to Euro 100,000 for basic and/or clinical projects. The duration of each award may be one year or longer, depending upon the needs of the project and as justified in the application.
Applications for an EFSD/Sanofi grant are invited from single non-profit institutions or groups of such institutions from Europe and associated countries. The principal investigator and any co-investigators must be employed full-time at a non-profit institution and the study must be performed at their place of work.
The deadline for receipt of research grant applications for funding is 16 March 2020.